USP52 interacts with YAP and inhibits YAP polyubiquitination and breakdown, which further decreases the sensitivity of CRC cells to ferroptosis and ultimately attenuates immunotherapy efficacy (Fig. 8). This evidence concerns the gene PAN2 and colorectal carcinoma.